PDB Short entry for 4ZZY HEADER TRANSFERASE 15-APR-15 4ZZY TITLE STRUCTURE OF HUMAN PARP2 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 223-583; COMPND 5 SYNONYM: PARP-2, HPARP-2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LI COMPND 6 KE 2, ARTD2, NAD(+) ADP-RIBOSYLTRANSFERASE 2, ADPRT-2, POLYADP-RIB COMPND 7 OSE SYNTHASE 2, PADPRT-2, PARP-2, HPARP-2, ADP-RIBOSYLTRANSFERASE COMPND 8 DIPHTHERIA TOXIN-LIKE 2, ARTD2, NAD(+) ADP-RIBOSYLTRANSFERASE 2, A COMPND 9 DPRT-2, POLYADP- RIBOSE SYNTHASE 2, PADPRT-2, POLY ADP-RIBOSE POLY COMPND 10 MERASE 2, POLY ADP-RIBOSE POLYMERASE 2; COMPND 11 EC: 2.4.2.30; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.CASALE,M.FASOLINI,G.PAPEO,H.POSTERI,D.BORGHI,A.A.BUSEL,F.CAPRERA, AUTHOR 2 M.CIOMEI,A.CIRLA,E.CORTI,M.DANELLO,M.FASOLINI,E.R.FELDER,B.FORTE, AUTHOR 3 A.GALVANI,A.ISACCHI,A.KHVAT,M.Y.KRASAVIN,R.LUPI,P.ORSINI,R.PEREGO, AUTHOR 4 E.PESENTI,D.PEZZETTA,S.RAINOLDI,F.RICCARDISIRTORI,A.SCOLARO,F.SOLA, AUTHOR 5 F.ZUCCOTTO,D.DONATI,A.MONTAGNOLI REVDAT 3 10-JAN-24 4ZZY 1 REMARK REVDAT 2 23-SEP-15 4ZZY 1 JRNL REVDAT 1 12-AUG-15 4ZZY 0 JRNL AUTH G.M.E.PAPEO,H.POSTERI,D.BORGHI,A.A.BUSEL,F.CAPRERA,E.CASALE, JRNL AUTH 2 M.CIOMEI,A.CIRLA,E.CORTI,M.D'ANELLO,M.FASOLINI,B.FORTE, JRNL AUTH 3 A.GALVANI,A.ISACCHI,A.KHVAT,M.Y.KRASAVIN,R.LUPI,P.ORSINI, JRNL AUTH 4 R.PEREGO,E.PESENTI,D.PEZZETTA,S.RAINOLDI,F.RICCARDI-SIRTORI, JRNL AUTH 5 A.SCOLARO,F.SOLA,F.ZUCCOTTO,E.R.FELDER,D.DONATI,A.MONTAGNOLI JRNL TITL DISCOVERY OF JRNL TITL 2 2-[1-(4,4-DIFLUOROCYCLOHEXYL) JRNL TITL 3 PIPERIDIN-4-YL]-6-FLUORO-3-OXO-2, JRNL TITL 4 3-DIHYDRO-1H-ISOINDOLE-4-CARBOXAMIDE (NMS-P118): A POTENT, JRNL TITL 5 ORALLY AVAILABLE AND HIGHLY SELECTIVE PARP- 1 INHIBITOR FOR JRNL TITL 6 CANCER THERAPY. JRNL REF J.MED.CHEM. V. 58 6875 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26222319 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00680 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 20733 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1122 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1334 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE SET COUNT : 83 REMARK 3 BIN FREE R VALUE : 0.3960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2796 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.04000 REMARK 3 B22 (A**2) : -1.04000 REMARK 3 B33 (A**2) : 2.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.273 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.235 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.179 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.135 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.883 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2886 ; 0.016 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3901 ; 1.856 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 349 ; 6.767 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;37.847 ;24.462 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 524 ;18.138 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;20.757 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 427 ; 0.115 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2152 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4ZZY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-APR-15. REMARK 100 THE DEPOSITION ID IS D_1290063603. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21921 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3KCZ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG4000, 0.2M MAGNESIUM CLORIDE, REMARK 280 0.1 M TRIS PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.23150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.18850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.18850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 111.34725 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.18850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.18850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.11575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.18850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.18850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 111.34725 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.18850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.18850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.11575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 74.23150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 221 REMARK 465 PRO A 222 REMARK 465 SER A 223 REMARK 465 LEU A 224 REMARK 465 LYS A 225 REMARK 465 SER A 226 REMARK 465 PRO A 227 REMARK 465 LEU A 228 REMARK 465 LYS A 229 REMARK 465 PRO A 230 REMARK 465 PRO A 549 REMARK 465 ASP A 550 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 363 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 353 135.60 163.75 REMARK 500 GLN A 510 71.08 33.34 REMARK 500 ALA A 522 150.85 179.96 REMARK 500 VAL A 529 -168.72 -119.51 REMARK 500 ARG A 570 -43.05 -138.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D7N A 1584 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZZX RELATED DB: PDB REMARK 900 STRUCTURE OF PARP2 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 4ZZZ RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 5A00 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLY221 AND PRO222 ARE EXPRESSION TAG DBREF 4ZZY A 223 583 UNP Q9UGN5 PARP2_HUMAN 223 583 SEQADV 4ZZY GLY A 221 UNP Q9UGN5 EXPRESSION TAG SEQADV 4ZZY PRO A 222 UNP Q9UGN5 EXPRESSION TAG SEQRES 1 A 363 GLY PRO SER LEU LYS SER PRO LEU LYS PRO GLU SER GLN SEQRES 2 A 363 LEU ASP LEU ARG VAL GLN GLU LEU ILE LYS LEU ILE CYS SEQRES 3 A 363 ASN VAL GLN ALA MET GLU GLU MET MET MET GLU MET LYS SEQRES 4 A 363 TYR ASN THR LYS LYS ALA PRO LEU GLY LYS LEU THR VAL SEQRES 5 A 363 ALA GLN ILE LYS ALA GLY TYR GLN SER LEU LYS LYS ILE SEQRES 6 A 363 GLU ASP CYS ILE ARG ALA GLY GLN HIS GLY ARG ALA LEU SEQRES 7 A 363 MET GLU ALA CYS ASN GLU PHE TYR THR ARG ILE PRO HIS SEQRES 8 A 363 ASP PHE GLY LEU ARG THR PRO PRO LEU ILE ARG THR GLN SEQRES 9 A 363 LYS GLU LEU SER GLU LYS ILE GLN LEU LEU GLU ALA LEU SEQRES 10 A 363 GLY ASP ILE GLU ILE ALA ILE LYS LEU VAL LYS THR GLU SEQRES 11 A 363 LEU GLN SER PRO GLU HIS PRO LEU ASP GLN HIS TYR ARG SEQRES 12 A 363 ASN LEU HIS CYS ALA LEU ARG PRO LEU ASP HIS GLU SER SEQRES 13 A 363 TYR GLU PHE LYS VAL ILE SER GLN TYR LEU GLN SER THR SEQRES 14 A 363 HIS ALA PRO THR HIS SER ASP TYR THR MET THR LEU LEU SEQRES 15 A 363 ASP LEU PHE GLU VAL GLU LYS ASP GLY GLU LYS GLU ALA SEQRES 16 A 363 PHE ARG GLU ASP LEU HIS ASN ARG MET LEU LEU TRP HIS SEQRES 17 A 363 GLY SER ARG MET SER ASN TRP VAL GLY ILE LEU SER HIS SEQRES 18 A 363 GLY LEU ARG ILE ALA PRO PRO GLU ALA PRO ILE THR GLY SEQRES 19 A 363 TYR MET PHE GLY LYS GLY ILE TYR PHE ALA ASP MET SER SEQRES 20 A 363 SER LYS SER ALA ASN TYR CYS PHE ALA SER ARG LEU LYS SEQRES 21 A 363 ASN THR GLY LEU LEU LEU LEU SER GLU VAL ALA LEU GLY SEQRES 22 A 363 GLN CYS ASN GLU LEU LEU GLU ALA ASN PRO LYS ALA GLU SEQRES 23 A 363 GLY LEU LEU GLN GLY LYS HIS SER THR LYS GLY LEU GLY SEQRES 24 A 363 LYS MET ALA PRO SER SER ALA HIS PHE VAL THR LEU ASN SEQRES 25 A 363 GLY SER THR VAL PRO LEU GLY PRO ALA SER ASP THR GLY SEQRES 26 A 363 ILE LEU ASN PRO ASP GLY TYR THR LEU ASN TYR ASN GLU SEQRES 27 A 363 TYR ILE VAL TYR ASN PRO ASN GLN VAL ARG MET ARG TYR SEQRES 28 A 363 LEU LEU LYS VAL GLN PHE ASN PHE LEU GLN LEU TRP HET D7N A1584 28 HETNAM D7N 2-[1-(4,4-DIFLUOROCYCLOHEXYL)-PIPERIDIN-4-YL]-6-FLUORO- HETNAM 2 D7N 3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXAMIDE FORMUL 2 D7N C20 H24 F3 N3 O2 FORMUL 3 HOH *80(H2 O) HELIX 1 1 ASP A 235 CYS A 246 1 12 HELIX 2 2 ASN A 247 MET A 258 1 12 HELIX 3 3 PRO A 266 LEU A 270 5 5 HELIX 4 4 THR A 271 ALA A 291 1 21 HELIX 5 5 GLY A 295 ILE A 309 1 15 HELIX 6 6 THR A 323 VAL A 347 1 25 HELIX 7 7 HIS A 356 HIS A 366 1 11 HELIX 8 8 SER A 376 THR A 389 1 14 HELIX 9 9 GLY A 411 PHE A 416 1 6 HELIX 10 10 ARG A 431 SER A 433 5 3 HELIX 11 11 ASN A 434 GLY A 442 1 9 HELIX 12 12 PRO A 451 TYR A 455 5 5 HELIX 13 13 MET A 466 ASN A 472 1 7 HELIX 14 14 TYR A 473 PHE A 475 5 3 HELIX 15 15 GLU A 506 GLN A 510 5 5 HELIX 16 16 SER A 524 PHE A 528 5 5 HELIX 17 17 ASN A 563 ASN A 565 5 3 SHEET 1 AA 5 CYS A 367 PRO A 371 0 SHEET 2 AA 5 TYR A 397 LYS A 409 -1 O GLU A 406 N ARG A 370 SHEET 3 AA 5 VAL A 567 PHE A 579 -1 O ARG A 570 N VAL A 407 SHEET 4 AA 5 THR A 482 ALA A 491 -1 O GLY A 483 N VAL A 575 SHEET 5 AA 5 ARG A 423 GLY A 429 -1 O MET A 424 N VAL A 490 SHEET 1 AB 4 ILE A 461 PHE A 463 0 SHEET 2 AB 4 GLU A 558 VAL A 561 -1 O TYR A 559 N PHE A 463 SHEET 3 AB 4 SER A 514 GLY A 517 -1 O THR A 515 N ILE A 560 SHEET 4 AB 4 CYS A 495 LEU A 498 1 O ASN A 496 N LYS A 516 SHEET 1 AC 2 MET A 521 ALA A 522 0 SHEET 2 AC 2 SER A 542 ASP A 543 -1 O SER A 542 N ALA A 522 SHEET 1 AD 2 VAL A 529 LEU A 531 0 SHEET 2 AD 2 SER A 534 VAL A 536 -1 O SER A 534 N LEU A 531 CISPEP 1 GLY A 539 PRO A 540 0 3.07 SITE 1 AC1 14 SER A 328 ILE A 331 GLN A 332 HIS A 428 SITE 2 AC1 14 GLY A 429 GLY A 454 TYR A 455 TYR A 462 SITE 3 AC1 14 PHE A 463 ALA A 464 LYS A 469 SER A 470 SITE 4 AC1 14 TYR A 473 GLU A 558 CRYST1 74.377 74.377 148.463 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013445 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013445 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006736 0.00000